Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
AltspaceVR: Socializing in a Virtual Environment
53:05 - AltspaceVR founder and CEO Eric Romo was the thirteenth employee hired at SpaceX and he's now using his background as an innovator to alter the way we socialize. (Source: Bloomberg)
  • Emerging Markets Approach 1998 Lows, Not Yet Oversold
  • High Wage Jobs See Most Increase, Harder to Fill
  • Rate Watch: Is Now the Right Time for an Increase?